Demography and disease characteristics of prostate cancer in India

Introduction: The incidence of prostate cancer has shown significant variation across the globe. Though the prevalence and characteristics of this disease have been extensively studied in many countries, data regarding the true incidence of prostate cancer in India is limited. Materials and Methods: MEDLINE publications from 1990 to 2014 were searched and reviewed and compiled to assess the demographic profile of prostate cancer in India and characteristics unique to this disease in India. Results: The limited data available on prostate cancer showed significant differences in incidence, precipitating factors, and disease characteristics of prostate cancer in India. Conclusions: Since India would be having more number of cases of prostate cancer than most others in the years to come, adequate population-based data regarding the demography and disease characteristics of this disease are of paramount importance in this country.

• Publication year

  2016

• Venue

  Indian Journal of Urology

• Publication date

  2016-04-01

• Fields of study

  Medicine, Sociology

• Identifiers
  DOI 10.4103/0970-1591.174774PMID 27127351PMCID 4831497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology of prostate cancer in India

  2014influential reference
• Raising cut-off value of prostate specific antigen (PSA) for biopsy in symptomatic men in India to reduce unnecessary biopsy

  2014cited by this paper
• Diagnosis and Progression of Prostate Cancer in North Indian Population: An Affect of Body Mass Index and Age -

  2013cited by this paper
• Prostate cancer disease characteristics for foreign-born South Asian men living in the United States.

  2013cited by this paper
• GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer

  2013cited by this paper
• Risk of Prostrate Cancer in Eastern India

  2012influential reference
• International variation in prostate cancer incidence and mortality rates.

  2012cited by this paper
• The burden of prostate cancer in Asian nations

  2012cited by this paper
• Estimation of time trends of incidence of prostate cancer--an Indian scenario.

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• Risk factors for prostate cancer: An hospital-based case-control study from Mumbai, India

  2011cited by this paper
• Gene-Environmental Interaction and Prostate Cancer: The Indian Scenario

  2011cited by this paper
• Effects of aging and ethnicity on serum free prostate specific antigen.

  2011cited by this paper
• Trends in cancer incidence in Chennai city (1982-2006) and statewide predictions of future burden in Tamil Nadu (2007-16).

  2011cited by this paper
• Pathological outcomes and strategies to achieve optimal cancer control during robotic radical prostatectomy in Asian-Indian men

  2011cited by this paper
• Cancer Scenario in India with Future Perspectives Research Article

  2011cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• A study on prostate specific antigen (PSA) with the ratio of free to total PSA

  2010cited by this paper
• The value of prostate-specific antigen in Asia

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies.

  2010cited by this paper
• A case control study on prostate cancer in Delhi.

  2010cited by this paper
• The routine use of prostate-specific antigen for early detection of cancer prostate in India: Is it justified?

  2009cited by this paper
• Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China.

  2009influential reference
• Pesticide use and application: an Indian scenario.

  2009cited by this paper
• CYP17 gene polymorphism and its association in north Indian prostate cancer patients.

  2009cited by this paper
• THE RISK OF PROSTATE CANCER AMONGST SOUTH ASIAN MEN IN SOUTHERN ENGLAND: THE PROCESS COHORT STUDY

  2009cited by this paper
• The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study

  2008cited by this paper
• Racial and ethnic variation of PSA in global population: Age specific reference intervals for serum prostate specific antigen in healthy South Indian males

  2008cited by this paper
• Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US.

  2008cited by this paper
• Trends in the prostate cancer incidence in India.

  2008cited by this paper
• Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population

  2007cited by this paper
• Sun Exposure and Prostate Cancer Risk: Evidence for a Protective Effect of Early-Life Exposure

  2007cited by this paper
• Prostate-specific antigen levels among Chinese, Malays and Indians in Singapore from a community-based study.

  2007cited by this paper
• Anthropometrics and prostate cancer risk.

  2007cited by this paper
• Stage at diagnosis and relative differences in breast and prostate cancer incidence in India: comparison with the United States.

  2006influential reference
• Prostate specific antigen in patients of benign prostate hypertrophy and carcinoma prostate

  2006cited by this paper
• Cancer incidence in the south Asian population of California, 1988–2000

  2005influential reference
• Changing demography of prostate cancer in Asia.

  2005cited by this paper
• Utility of Free/Total Prostate Specific Antigen (f/t PSA) Ratio in Diagnosis of Prostate Carcinoma

  2004cited by this paper
• Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.

  2004cited by this paper
• Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.

  2004cited by this paper
• Diabetes mellitus and risk of prostate cancer (United States)

  2004cited by this paper
• Comparative study of bone mineral density, calcium, and vitamin D status in the Gujarati and white populations of Leicester

  2003cited by this paper
• Cancer risk and diet in India.

  2003cited by this paper
• Cancer patterns in eastern India: The first report of the Kolkata cancer registry

  2002influential reference
• Fatty fish consumption and risk of prostate cancer.

  2001cited by this paper
• Family history and prostate cancer risk in a population-based cohort of Iowa men.

  1999cited by this paper
• Vasectomy and prostate cancer: a case-control study in India.

  1997cited by this paper
• Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States)

  1997cited by this paper
• Height, body weight, and risk of prostate cancer.

  1997cited by this paper
• [A case-control study of prostate cancer].

  1996cited by this paper
• Cancer profile in eastern Rajasthan.

  1992influential reference

• Survival outcomes in prostate cancer patients treated at an Indian tertiary care centre

  2026cites this paper
• IN VIVO ASSESSMENT OF POLYLACTIC CO-GLYCOLIC ACID NANOBUBBLES FOR TRIGGERED ENZALUTAMIDE DELIVERY: OPTIMIZATION, CHARACTERIZATION, AND DESIGN OF EXPERIMENTS-BASED EVALUATION

  2025cites this paper
• Evaluating the association of CYP17 and SRD5A2 gene polymorphisms with prostate Cancer risk: A case-control study in the male population of Jammu, India

  2025cites this paper
• Diagnostic Accuracy of Combination of Multiparametric MRI PI-RADS Score v2.1 and Prostate-Specific Antigen Density for Prostate Cancer Detection

  2025cites this paper
• Prostate-Related Germline Variant Frequencies Detected in a Cohort of Men With Metastatic Prostate Cancer in Northern India

  2025cites this paper
• Evolving Treatment Paradigms in Metastatic Hormone-Sensitive Prostate Cancer: Expert Narrative Review

  2025cites this paper
• Correlation of Immunohistochemical Expression of Alpha-Methyl Acyl-Coenzyme A Racemase/p504s with Gleason Grade and Serum PSA Level in Prostate Carcinoma

  2025cites this paper
• Prostate classification network (PC-Net) for automated classification of Prostate cancer in Magnetic resonance imaging

  2024cites this paper
• Assessment of age specific serum Prostate Specific Antigen (PSA) levels for Indian population: A retrospective analysis at a tertiary healthcare facility

  2024cites this paper
• Autoantibodies Targeting Prostate-specific Antigen: Implications in Prostate Cancer – A Narrative Review

  2024cites this paper
• Incidence of exclusive extrapelvic skeletal metastasis in prostate carcinoma on bone scintigraphy

  2024cites this paper
• Descriptive epidemiology of prostate cancer in India, 2012–2019: Insights from the National Cancer Registry Programme

  2024cites this paper
• Burden of Prostate Cancer, Prostate-specific Antigen Myths, and Optimal Prostate-specific Antigen Screening

  2024cites this paper
• Nanocarrier – Mediated Salinomycin Delivery Induces Apoptosis and Alters EMT Phenomenon in Prostate Adenocarcinoma

  2024cites this paper
• A hospital-based study of prostate biopsy results in Indian males

  2024cites this paper
• Anti-proliferative, Pro-apoptotic, and Chemosensitizing Potential of 3-Acetyl-11-keto-β-boswellic Acid (AKBA) Against Prostate Cancer Cells

  2024cites this paper
• Trends of Prostate Cancer Morbidity in Low-Incidence Countries from 1990–2019

  2024cites this paper
• Cost-Effectiveness Analysis of Systemic Therapy for Intensification of Treatment in Metastatic Hormone-Sensitive Prostate Cancer in India

  2024cites this paper
• Convoluted Neural Network for Detection of Clinically Significant Prostate Cancer on ^68 Ga PSMA PET/CT Delayed Imaging by Analyzing Radiomic Features

  2024cites this paper
• Current status and future readiness of Indian radiation oncologists to embrace prostate high-dose-rate brachytherapy: An Indian Brachytherapy Society survey

  2023cites this paper
• Expression of BAX and Bcl-2 gene in prostate carcinoma and its correlation with gleason score

  2023cites this paper
• Serum Prostate Specific Antigen and Mast Cells in Distinguishing Benign Prostatic Hyperplasia from Prostatic Carcinoma: Is there a Correlation?

  2023cites this paper
• Prostatic issues and Homoeopathic Approach

  2023cites this paper
• Comparative analysis of real-world data of frequent treatment sequences in metastatic prostate cancer

  2023cites this paper
• Association of Non-Genetic Risk Factors with Prostate Cancer in the Population of Jammu Region of J and K, India

  2023cites this paper
• Efficacy of Degarelix in the Neoadjuvant Setting in Managing Locally Advanced Prostate Cancer

  2023cites this paper
• An immunohistochemical evaluation of tumor-associated macrophages (M1 and M2) in carcinoma prostate – An institutional study

  2023cites this paper
• Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.

  2023cites this paper
• Combination Treatment of a Phytochemical and a Histone Demethylase Inhibitor—A Novel Approach towards Targeting TGFβ-Induced EMT, Invasion, and Migration in Prostate Cancer

  2023cites this paper
• Implications and relative importance of GSTP1, GSTM1, and GSTT1 Polymorphisms in the prevalence and severity of prostate cancer in an Eastern Indian Population

  2023cites this paper
• Access and barriers to genomic classifiers for breast cancer and prostate cancer in India

  2023cites this paper
• Study of histomorphological spectrum of eyelid lesions

  2023cites this paper
• Biosensors for detection of prostate cancer: a review

  2022cites this paper
• Natural Products as the Modulators of Oxidative Stress: An Herbal Approach in the Management of Prostate Cancer.

  2022cites this paper
• Raised prostate-specific antigen alone may not be a true predictor in high-risk prostate cancer: A retrospective cohort analysis

  2022cites this paper
• Case report of metachronous pleural mesothelioma with carcinoma prostate: Diagnostic dilemma

  2022cites this paper
• Differential Microbial Signature Associated With Benign Prostatic Hyperplasia and Prostate Cancer

  2022cites this paper
• Drug Repurposing: A New Hope in Drug Discovery for Prostate Cancer

  2022cites this paper
• To investigate the awareness about prostate cancer among rural populations

  2022cites this paper
• Whole-exome sequencing of Indian prostate cancer reveals a novel therapeutic target: POLQ

  2022cites this paper
• Case Report Prostate health in India (BPH & Prostate Cancer)

  2022cites this paper
• Prostate health in India (BPH & Prostate Cancer)

  2022cites this paper
• Multiparametric Magnetic Resonance Imaging, 68Ga Prostate-Specific Membrane Antigen Positron Emission Tomography–Computed Tomography, and Respective Quantitative Parameters in Detection and Localization of Clinically Significant Prostate Cancer in Intermediate- and High-Risk Group Patients: An India

  2021influential citation
• Prostate-specific antigen screening of men with lower urinary tract symptoms (opportunistic screening) and of asymptomatic men undergoing executive health check: an audit from two institutions

  2021cites this paper
• Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 2 of 2

  2021cites this paper
• Metastatic Thyroid Cartilage Lesion from Prostatic Adenocarcinoma on 68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography Scan: Case Series

  2021cites this paper
• Robot-assisted radical prostatectomy in indian men of age 75 years and above: a propensity score-matched analysis

  2021cites this paper
• Natural Product-Based Studies for the Management of Castration-Resistant Prostate Cancer: Computational to Clinical Studies

  2021cites this paper
• CARDIOVASCULAR RISK ASSOCIATED WITH ANDROGEN DEPRIVATION THERAPY IN ADVANCED PROSTATE CANCER

  2021cites this paper
• Role of 68Ga-PSMA-PET/CT for the detection of primary prostate cancer prior to biopsy: a prospective study

  2021cites this paper
• ENHANCED ANTICANCER POTENCY OF GEMCITABINE IN COMBINATION WITH PROPOFOL IN PROSTATE CANCER

  2021cites this paper
• Cancer in the older Indian population: Understanding the current context in an emerging economy.

  2021cites this paper
• Hypoehoic lesions on Transrectal Ultrasound and its correlation to Gleason grade in the diagnosis of Clinically Significant Prostate Cancer: A Prospective Study

  2021cites this paper
• Does prior transurethral resection of prostate affect the functional and oncological outcomes of robot-assisted radical prostatectomy? A matched-pair analysis

  2021cites this paper
• TRANSRECTAL ULTRASONOGRAPHY AND MAGNETIC RESONANCE IMAGING (MRI) CORRELATION IN PATIENTS HAVING PROSTATIC PATHOLOGY.

  2021cites this paper
• Anticancer effect of Digera muricata Leaf Extract against Prostate Cancer Cell Lines

  2021cites this paper
• A Prospective Study to Assess the Impact of Neoadjuvant Androgen Deprivation Therapy on Tumor Volume, Rectal and Bladder Doses with Image Guided Radiation Therapy in Locally Advanced Prostate Cancer

  2021cites this paper
• Variations of Serum PSA Values at Different Time Points of Treatment Based on D’Amico Risk Stratification Groups- An Observational Analysis

  2020cites this paper
• Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 1 of 2

  2020cites this paper
• Special emphasis on bone health management in prostate cancer patients: a prospective longitudinal study

  2020cites this paper
• The Impact of Total PSA Value on Diagnosis of Prostate Diseases in Sudanese Patient

  2020influential citation
• Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL)

  2020cites this paper
• Association of Monoamine Oxidase A with Tumor Burden and Castration Resistance in Prostate Cancer

  2020cites this paper
• Diagnostic Accuracy of Prebiopsy Ga-68 PSMA PET/CT in Detecting Primary Prostate Carcinomas with Prostate-Specific Antigen <50 ng/ml

  2020cites this paper
• Coverage and Evolution of Cancer and Its Risk Factors - A Quantitative Study with Social Signals and Web-Data

  2020cites this paper
• Food Enhanced Pharmacokinetics for Clinical Translation of Low Dose Abiraterone Acetate in Metastatic Castration-Resistant Prostate

  2020cites this paper
• Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma

  2020cites this paper
• Cellular growth factors as prospective therapeutic targets for combination therapy in androgen independent prostate cancer (AIPC).

  2020cites this paper
• In silico docking of phytocompounds to identify potent inhibitors of signaling pathways involved in prostate cancer

  2020cites this paper
• Age-specific survival in prostate cancer using machine learning

  2020cites this paper
• Dosimetric comparison of single and double collimator stereotactic body radiotherapy plans using Cyber Knife for carcinoma prostate

  2020cites this paper
• Early Chemotherapy in Metastatic Prostate Cancer Improves Survival: a Quick Note to Surgical Colleagues

  2020cites this paper
• In-Vitro Anticancer Activity Of Hydroalcoholic Extract Of Senna Alata

  2019cites this paper
• DIAGNOSTIC UTILITY OF AMACR EXPRESSION TO DIFFERENTIATE PROSTATE CARCINOMA FROM BENIGN HYPERPLASIA OF PROSTATE- A HOSPITAL BASED CROSS-SECTIONAL STUDY

  2019cites this paper
• Usefulness of Transrectal Ultrasound for Predicting Carcinoma of Prostate

  2019cites this paper
• Multiparametric Magnetic Resonance Imaging of the Prostate: An Update

  2019cites this paper
• Role Of Free / Total Psa Ratio To Differentiate Bph And Prostate Cancer

  2019cites this paper
• Gene Expression-Based Supervised Classification Models for Discriminating Early- and Late-Stage Prostate Cancer

  2019cites this paper
• Multiparametric MRI Approach to Prostate Cancer with a Pictorial Essay on PI-RADS

  2019cites this paper
• Prostate Radiotherapy in India: Evolution, Practice and Challenges in the 21st Century.

  2019cites this paper
• Histomorphological study of prostatic adenocarcinoma and its mimics

  2019cites this paper
• Epidemiology of prostate cancer in Asian countries

  2018cites this paper
• Sexual Activity and Risk of Prostate Cancer: A Dose-Response Meta-Analysis.

  2018cites this paper
• NRH:quinone oxidoreductase 2 (NQO2) and glutaminase (GLS) both play a role in large extracellular vesicles (LEV) formation in preclinical LNCaP‐C4‐2B prostate cancer model of progressive metastasis

  2018cites this paper
• DIAGNOSTIC EFFICACY OF PROSTATE SPECIFIC ANTIGEN LEVELS IN PROSTATIC LESIONS

  2018cites this paper
• Role of nm23H1 in predicting metastases in prostatic carcinoma

  2018cites this paper
• Evaluation of in vitro antioxidant and anticancer activity of Allophylus cobbe leaf extracts on DU-145 and PC-3 human prostate cancer cell lines

  2017cites this paper
• Study of transrectal ultrasound guided biopsies of prostate in correlation with serum prostate specific antigen level

  2017influential citation
• Accuracy of Diffusion Weighted Images and MR Spectroscopy in Prostate Lesions - Our Experience with Endorectal Coil on 1.5 T MRI.

  2017cites this paper
• In vitro antioxidant and anticancer activity of Leea indica leaf extracts on human prostate cancer cell lines

  2017cites this paper
• TRUS Biopsy Yield in Indian Population: A Retrospective Analysis.

  2017cites this paper
• Is PSMA PET-CT Better than Bone Scan? When and Why

  2017cites this paper
• Patient-reported outcomes: The next step?

  2016cites this paper
• Incidence of prostate cancer at a single tertiary care center in North Karnataka.

  2016cites this paper